img

Global Central Nervous System Disorders Therapeutics Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Central Nervous System Disorders Therapeutics Market Research Report 2024

Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both.
According to MRAResearch’s new survey, global Central Nervous System Disorders Therapeutics market is projected to reach US$ 169200 million in 2033, increasing from US$ 128930 million in 2022, with the CAGR of 3.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Central Nervous System Disorders Therapeutics market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Central Nervous System Disorders Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
Novartis
Pfizer
Segment by Type
Depression
MS
bipolar disorder
schizophrenia
epilepsy
AD
Parkinson' s
others

Segment by Application


Clinicals
Hospitials
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Central Nervous System Disorders Therapeutics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System Disorders Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Depression
1.2.3 MS
1.2.4 bipolar disorder
1.2.5 schizophrenia
1.2.6 epilepsy
1.2.7 AD
1.2.8 Parkinson' s
1.2.9 others
1.3 Market by Application
1.3.1 Global Central Nervous System Disorders Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Clinicals
1.3.3 Hospitials
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System Disorders Therapeutics Market Perspective (2018-2033)
2.2 Central Nervous System Disorders Therapeutics Growth Trends by Region
2.2.1 Global Central Nervous System Disorders Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Central Nervous System Disorders Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Central Nervous System Disorders Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Central Nervous System Disorders Therapeutics Market Dynamics
2.3.1 Central Nervous System Disorders Therapeutics Industry Trends
2.3.2 Central Nervous System Disorders Therapeutics Market Drivers
2.3.3 Central Nervous System Disorders Therapeutics Market Challenges
2.3.4 Central Nervous System Disorders Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System Disorders Therapeutics Players by Revenue
3.1.1 Global Top Central Nervous System Disorders Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Central Nervous System Disorders Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Central Nervous System Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Central Nervous System Disorders Therapeutics Revenue
3.4 Global Central Nervous System Disorders Therapeutics Market Concentration Ratio
3.4.1 Global Central Nervous System Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System Disorders Therapeutics Revenue in 2022
3.5 Central Nervous System Disorders Therapeutics Key Players Head office and Area Served
3.6 Key Players Central Nervous System Disorders Therapeutics Product Solution and Service
3.7 Date of Enter into Central Nervous System Disorders Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Central Nervous System Disorders Therapeutics Breakdown Data by Type
4.1 Global Central Nervous System Disorders Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Central Nervous System Disorders Therapeutics Forecasted Market Size by Type (2024-2033)
5 Central Nervous System Disorders Therapeutics Breakdown Data by Application
5.1 Global Central Nervous System Disorders Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Central Nervous System Disorders Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Central Nervous System Disorders Therapeutics Market Size (2018-2033)
6.2 North America Central Nervous System Disorders Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Central Nervous System Disorders Therapeutics Market Size by Country (2018-2023)
6.4 North America Central Nervous System Disorders Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Central Nervous System Disorders Therapeutics Market Size (2018-2033)
7.2 Europe Central Nervous System Disorders Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Central Nervous System Disorders Therapeutics Market Size by Country (2018-2023)
7.4 Europe Central Nervous System Disorders Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Central Nervous System Disorders Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Central Nervous System Disorders Therapeutics Market Size (2018-2033)
9.2 Latin America Central Nervous System Disorders Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Central Nervous System Disorders Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Central Nervous System Disorders Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Central Nervous System Disorders Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Central Nervous System Disorders Therapeutics Introduction
11.1.4 Eli Lilly Revenue in Central Nervous System Disorders Therapeutics Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Central Nervous System Disorders Therapeutics Introduction
11.2.4 GlaxoSmithKline Revenue in Central Nervous System Disorders Therapeutics Business (2018-2023)
11.2.5 GlaxoSmithKline Recent Development
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Company Detail
11.3.2 Janssen Pharmaceuticals Business Overview
11.3.3 Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Introduction
11.3.4 Janssen Pharmaceuticals Revenue in Central Nervous System Disorders Therapeutics Business (2018-2023)
11.3.5 Janssen Pharmaceuticals Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Central Nervous System Disorders Therapeutics Introduction
11.4.4 Novartis Revenue in Central Nervous System Disorders Therapeutics Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Central Nervous System Disorders Therapeutics Introduction
11.5.4 Pfizer Revenue in Central Nervous System Disorders Therapeutics Business (2018-2023)
11.5.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Central Nervous System Disorders Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Depression
Table 3. Key Players of MS
Table 4. Key Players of bipolar disorder
Table 5. Key Players of schizophrenia
Table 6. Key Players of epilepsy
Table 7. Key Players of AD
Table 8. Key Players of Parkinson' s
Table 9. Key Players of others
Table 10. Global Central Nervous System Disorders Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Central Nervous System Disorders Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 12. Global Central Nervous System Disorders Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Central Nervous System Disorders Therapeutics Market Share by Region (2018-2023)
Table 14. Global Central Nervous System Disorders Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 15. Global Central Nervous System Disorders Therapeutics Market Share by Region (2024-2033)
Table 16. Central Nervous System Disorders Therapeutics Market Trends
Table 17. Central Nervous System Disorders Therapeutics Market Drivers
Table 18. Central Nervous System Disorders Therapeutics Market Challenges
Table 19. Central Nervous System Disorders Therapeutics Market Restraints
Table 20. Global Central Nervous System Disorders Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Central Nervous System Disorders Therapeutics Market Share by Players (2018-2023)
Table 22. Global Top Central Nervous System Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Disorders Therapeutics as of 2022)
Table 23. Ranking of Global Top Central Nervous System Disorders Therapeutics Companies by Revenue (US$ Million) in 2022
Table 24. Global 5 Largest Players Market Share by Central Nervous System Disorders Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Central Nervous System Disorders Therapeutics Product Solution and Service
Table 27. Date of Enter into Central Nervous System Disorders Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Central Nervous System Disorders Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Central Nervous System Disorders Therapeutics Revenue Market Share by Type (2018-2023)
Table 31. Global Central Nervous System Disorders Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 32. Global Central Nervous System Disorders Therapeutics Revenue Market Share by Type (2024-2033)
Table 33. Global Central Nervous System Disorders Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Central Nervous System Disorders Therapeutics Revenue Market Share by Application (2018-2023)
Table 35. Global Central Nervous System Disorders Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 36. Global Central Nervous System Disorders Therapeutics Revenue Market Share by Application (2024-2033)
Table 37. North America Central Nervous System Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Central Nervous System Disorders Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Central Nervous System Disorders Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Central Nervous System Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Europe Central Nervous System Disorders Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Central Nervous System Disorders Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 43. Asia-Pacific Central Nervous System Disorders Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 44. Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Central Nervous System Disorders Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 46. Latin America Central Nervous System Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Latin America Central Nervous System Disorders Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Central Nervous System Disorders Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 49. Middle East & Africa Central Nervous System Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 50. Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Central Nervous System Disorders Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 52. Eli Lilly Company Detail
Table 53. Eli Lilly Business Overview
Table 54. Eli Lilly Central Nervous System Disorders Therapeutics Product
Table 55. Eli Lilly Revenue in Central Nervous System Disorders Therapeutics Business (2018-2023) & (US$ Million)
Table 56. Eli Lilly Recent Development
Table 57. GlaxoSmithKline Company Detail
Table 58. GlaxoSmithKline Business Overview
Table 59. GlaxoSmithKline Central Nervous System Disorders Therapeutics Product
Table 60. GlaxoSmithKline Revenue in Central Nervous System Disorders Therapeutics Business (2018-2023) & (US$ Million)
Table 61. GlaxoSmithKline Recent Development
Table 62. Janssen Pharmaceuticals Company Detail
Table 63. Janssen Pharmaceuticals Business Overview
Table 64. Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Product
Table 65. Janssen Pharmaceuticals Revenue in Central Nervous System Disorders Therapeutics Business (2018-2023) & (US$ Million)
Table 66. Janssen Pharmaceuticals Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis Central Nervous System Disorders Therapeutics Product
Table 70. Novartis Revenue in Central Nervous System Disorders Therapeutics Business (2018-2023) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Pfizer Company Detail
Table 73. Pfizer Business Overview
Table 74. Pfizer Central Nervous System Disorders Therapeutics Product
Table 75. Pfizer Revenue in Central Nervous System Disorders Therapeutics Business (2018-2023) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Central Nervous System Disorders Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Central Nervous System Disorders Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Depression Features
Figure 4. MS Features
Figure 5. bipolar disorder Features
Figure 6. schizophrenia Features
Figure 7. epilepsy Features
Figure 8. AD Features
Figure 9. Parkinson' s Features
Figure 10. others Features
Figure 11. Global Central Nervous System Disorders Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 12. Global Central Nervous System Disorders Therapeutics Market Share by Application: 2022 VS 2033
Figure 13. Clinicals Case Studies
Figure 14. Hospitials Case Studies
Figure 15. Central Nervous System Disorders Therapeutics Report Years Considered
Figure 16. Global Central Nervous System Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Central Nervous System Disorders Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Central Nervous System Disorders Therapeutics Market Share by Region: 2022 VS 2033
Figure 19. Global Central Nervous System Disorders Therapeutics Market Share by Players in 2022
Figure 20. Global Top Central Nervous System Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Disorders Therapeutics as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Central Nervous System Disorders Therapeutics Revenue in 2022
Figure 22. North America Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Central Nervous System Disorders Therapeutics Market Share by Country (2018-2033)
Figure 24. United States Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Central Nervous System Disorders Therapeutics Market Share by Country (2018-2033)
Figure 28. Germany Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Central Nervous System Disorders Therapeutics Market Share by Region (2018-2033)
Figure 36. China Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Central Nervous System Disorders Therapeutics Market Share by Country (2018-2033)
Figure 44. Mexico Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Central Nervous System Disorders Therapeutics Market Share by Country (2018-2033)
Figure 48. Turkey Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Central Nervous System Disorders Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Eli Lilly Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2018-2023)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2018-2023)
Figure 52. Janssen Pharmaceuticals Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2018-2023)
Figure 53. Novartis Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2018-2023)
Figure 54. Pfizer Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries